NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes

NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes

ABSTRACTBackground and aim Diabetic nephropathy (DN) is a major microvascular diabetic complication representing the key leading reason for end-stage renal disease (ESRD). The current work aimed to evaluate the value of urinary and serum NGAL (neutrophil gelatinase-associating lipocalin), as an earl...

Full description

Bibliographic Details
Main Authors: Magdy Helmy Zikry Megallaa, Mohamed Said Abdel Salam, Neveen Lewis Mikhael Saad, Mohamed Nagy Abdel Hay Ahmed Altair, Noha Gaber Amin
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Alexandria Journal of Medicine
Subjects:
Diabetic nephropathy
albuminuria
neutrophil gelatinase-associated lipocalin
Online Access:https://www.tandfonline.com/doi/10.1080/20905068.2023.2230051

Internet

https://www.tandfonline.com/doi/10.1080/20905068.2023.2230051

Similar Items